Avipep is developing improved diagnostic and therapeutic products to address unmet clinical treatments for prostate, colorectal and breast cancers.
Our product pipeline focuses on clinically-validated targets that can deliver to a large target population.
Research and Development Pipeline
|Design/ Engineer||Optimize/ Selection||In vitro stability Proof of Concept||In vivo Proof of Concept||cGMP process development||Safety/ Toxicology||IND||Phase I/II||Out-license Partner|
|Antigen type||Call surface glycoprotein||Cell surface protein||Surface bound enzyme||cell surface receptor|
System Lupus Erythematosus
|Human validation of targets||Yes||Yes||Yes||Yes|